You are here

Home » Content

DÎYABETÎK HASTALARDA SÜREKLİ AYAKTAN PERİTON DİYALİZ TEDAVİSİ

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN DIABETIC PATIENTS

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 1995

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
According to recent reports, the most common cause of chronic renal failure (CRF) is diabetic nephropathy. United States Renal Data System (USRDS) showed that in 1989, 3 % of all new CRF patients accepted for renal replacement therapy (RRT) were diabetic. This ratio has been increasing from 3 % to 35 % since 1989. Renal replacement therapy modalities such as renal - renal & pancreas transplantation, hemodialysis and continuous peritoneal dialysis are recommended for end-stage diabetic nephropathy patients. In recent years, Continuous Ambulatory Peritoneal Dialysis (CAPD) is the first choice of RRT for these patients as the control of hypertension and hyperglicemia and preservation of residual renal functions are excellent. In this lecture, CAPD in diabetics was rewieved.
Bookmark/Search this post with
Abstract (Original Language): 
Son yıllardaki değerlendirmelere göre kronik böbrek yetmezliğinin en sık nedeni diyabetik nefropatidir. Renal replasman tedavisi görenlerin Amerika Birle¬şik Devletleri Böbrek Hastalıkları Bilgi Sistemine (USRDS) göre 1989yılında % 3ü diyabetik nefropa-tili hastalar iken, 1991 'de % 33.8'e ve günümüzde % 35'e ulaşmıştır. Son dönem böbrek yetmezliği ile so¬nuçlanan diyabetik nefropatili hastalara diğer hasta gruplarında olduğu gibi böbrek veya böbrek-pankre-as transplantasyonu, hemodiyaliz ve sürekli periton diyalizinden oluşan başlıca 3 tip renal replasman te¬davisi uygulanabilir. Günümüzde son dönem diyabetik nefropatili hasta¬ların çoğuna ilk tedavi seçeneği olarak hipertansiyon ve hipergliseminin mükemmel kontrolü ve residüel re¬nal fonksiyonların korunması nedeniyle Continuous Ambulatory Peritoneal Dialysis (CAPD) - Sürekli Ayaktan Periton Diyalizi (SAPD) uygulanmaktadır. Bu yazıda diyabetiklere uygulanan SAPD tedavisine genel bir bakış yapılacak, bu tedavinin uygulanma esasları, avantaj ve dezavantajları belirtilecektir. Di-yabetik hastalara uygulanan SAPD tedavisindeki mo¬dern görüşler aktarılmaya çalışılacaktır.
FULL TEXT (PDF): 
PDF icon pdf_tndt_96.pdf
  • 3
131-137
  • Turkish

REFERENCES

References: 

1. Raine G. The rising tide of diabetic nephropathy - the warning before the flood?. Nephrol Dial Transplant 1995; 10: 460-461
2. Lippert J, Ritz E, Schwarzbeck and Schneider P. The ri¬sing tide of endstage renal failure from diabetic nephro-pathy type II - an epidemiological analysis. Nephrol Dial Transplant 1995;10:462A67
3. Brunner FP, Brynger H, Challah S et al. Renal replace¬ment therapy in patients with diabetic nephro-
pathy,1980-1985. Nephrol Dial Transplant 1988;3:585-
589
4. Valderrabano F. EDTA registry annual report on mana¬gement of renal failure in Europe, XXIV, 1993, EDTA Annual Congress 1994;Vienna
5. Hasslancher C, Ritz E, Wahl P et al. Similar risks of nephropathy in patients with type I or type II diabetes
mellitus. Nephrol Dial Transplant 1989;4:859-863
6. Passlick J, Grabensee B. CAPD and transplantation in
diabetics. Clin Nephrol 1988;3O(S1):S18-S23
7. Viglino G, Cancarini C, Catizone R et al. Ten years ex¬perience of CAPD in diabetics: comparison of results with non-diabetics. Nephrol Dial Transplant 1994;9:1443-1448
8. Siileymanlar G. ve ark.
Türkiye'd
e renal replasman teda¬visi gören hastaların özellikleri, 1995 yılı verileri. XII. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon Kongresi Bolu, 1995
9. Balaskas EV, Yuan ZY, Gupta A et al. Long-term conti¬nuous ambulatory peritoneal dialysis in diabetics. Clin
Nephrol 1994;42(l):54-62
10. Khanna R, Nolph K, Oreopoulos D. Peritoneal dialysis in diabetics. Khanna R, Nolph K, Oreopoulos D (ed.): The essentials of peritoneal dialysis, Kluver Academic
Publishers, London, 1993, pp 99-105.
11.
Genti
l A.M, Carriazo A, Pavon I et al. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital haemodialysis: A multicentric study. Neph-
rol Dial Transplant 1991;6:444-451
12. Rottembourg J. Peritoneal dialysis in diabetics. Nolph K (ed.): Peritoneal dialysis, third edition, Kluver Academic
Publishers, London, 1990, pp 365-380.
13. Okado M, Tanaka Y, Kasida M et al. Two case reports of refractory heart failure treated by continuous ambula¬tory peritonea' dialysis. Kokyu To Junkan 1993; 41(10): 1013-1018
14. Catalano C, Postorino M, Kelly P.J et al. Diabetes melli-tus and renal replacement therapy in Italy: Prevalen-ce.main characteristics and complications. Nephrol Dial
Transplant 1990;5:788-796
15. Lameire N, Faict D. Peritoneal dialysis solutions contai¬ning glycerol and amino acids. Perit Dial Int 1994;14(S3):S145-S151
16. Spinowitz B.S, Gupta B.K, Kulogowski J. Dialysis ade¬quacy in hypoalbuminemic continuous ambulatory peritoneal dialysis patients. Perit Dial Intern 1993;!3 (S2):S221-S223
135
17. Tzamaloukas A.H, Murata G.H, Fox L. Peritoneal catheter loss and death in continuous ambulatory peritoneal dialysis peritonitis: correlation with clinical and bioche¬mical parameters. Perit Dial Int 1993;13(S2):S338-S340
18. Gallar P, Oliet A, Vigil A et al. Gastroparesis: an impor¬tant cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin. Perit Dial Int 1993;13(S2):S183-S186
19. Wei S.S, Lee G.S, Woo K.T et al. Ann Acad Med Singa¬pore 1993;22(4)-.629-633
20. Chan E, Montgomery P.A. Administration of insulin by continuous ambulatory peritoneal dialysis. Pharmacothe-rapy 1993;13(5)-.455-460
21. Scarpioni L, Ballocchi S, Castelli A et al. Insulin the¬rapy in uremic diabetic patients on continuous ambula¬tory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration. Perit Dial Int 1994;14(2):127-131
22. Widcrol T.E. Intraperitoneal insulin absorbtion during intermittant and continuous peritoneal dialysis . Kidney
Int 1983;23:22-28
23. Lye W.C, Leong S.O, Van-dcr-Straaten J.C et al. A prospective study of peritoneal dialysis-related infecti¬ons in CAPD patients with diabetes mellitus. Adv Perit Dial 1993;9:195-197
24. Tielens E, Nube M.J, de-Vet J.A et al. Major reduction of CAPD peritonitis after the introduction of the twin-
bag system. Nephrol Dial Transplant 1993;8(11):1237-1243
25. Zent R, Myers J.E, Donald D. Continuous ambulatory peritoneal dialysis: an option in the developing world?. Perit Dial Int 1994;14(1):48-51
26. Rottembourg J. Proc Eur Dial Transp Ass 1984;21:330-
334
136

Thank you for copying data from http://www.arastirmax.com